Position in BIOA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$913,071
+$647,801 QoQ
Shares Held
37,253
+145.6% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#74
of 151 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Derivatives in BIOA
reported options exposure · as of Jun 30, 2026CallValue
$12,500
CallShares
510
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $11,824,818 across 15 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,981 | $7,575,324 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,934 | $1,023,041 | |
| 3 | BIOA |
BioAge Labs, Inc.
This page
|
37,253 | $913,071 | |
| 4 | ALKS |
Alkermes plc.
|
9,338 | $489,311 | |
| 5 | LQDA |
Liquidia Corp
|
6,005 | $478,777 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,903 | $432,998 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
35,661 | $282,435 | |
| 8 | HROW |
Harrow, Inc.
|
3,986 | $169,285 |
All Filings in BIOA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,500 | 510 | Call | Sole | 2026-08-07 | |
| 2026-06-30 | $913,071 | 37,253 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $265,270 | 15,167 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $962,800 | 72,774 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||